熱門資訊> 正文
Terns Pharmaceuticals任命新首席财务官
2025-02-25 05:20
- Terns Pharmaceuticals (NASDAQ:TERN) announced the appointment of Andrew Gengos as chief financial officer, effective immediately.
- Gengos most recently, served as the chief financial officer of Athira Pharma (ATHA).
- Source: Press release
More on Terns Pharmaceuticals
- Terns Pharma: I Don't See The Positioning
- SA Asks: Which biotechs are most likely to be acquired near-term?
- Seeking Alpha’s Quant Rating on Terns Pharmaceuticals
- Historical earnings data for Terns Pharmaceuticals
- Financial information for Terns Pharmaceuticals
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。